Independent news has never been so important.

Did you know that you can get Democracy Now! delivered to your inbox every day? Sign up for our Daily News Digest today! Don't worry, we'll never share or sell your information.

South Africa Switches to Johnson & Johnson Vaccine in Battle Against Coronavirus Variant

HeadlineFeb 19, 2021

In South Africa, health authorities have launched a trial campaign of the Johnson & Johnson COVID-19 vaccine as they battle a coronavirus variant that’s become dominant across southern Africa. The pivot to the Johnson & Johnson vaccine came after a small clinical trial showed the AstraZeneca vaccine failed to prevent most cases of mild and moderate disease in South Africa. South African officials have pledged to share unused doses of the AstraZeneca shot with other African nations.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation